BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 33788974)

  • 1. Mitochondria antioxidant protection against cardiovascular dysfunction programmed by early-onset gestational hypoxia.
    Spiroski AM; Niu Y; Nicholas LM; Austin-Williams S; Camm EJ; Sutherland MR; Ashmore TJ; Skeffington KL; Logan A; Ozanne SE; Murphy MP; Giussani DA
    FASEB J; 2021 May; 35(5):e21446. PubMed ID: 33788974
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo mitochondria-targeted protection against uterine artery vascular dysfunction and remodelling in rodent hypoxic pregnancy.
    Wang Z; Camm EJ; Nuzzo AM; Spiroski AM; Skeffington KL; Ashmore TJ; Rolfo A; Todros T; Logan A; Ma J; Murphy MP; Niu Y; Giussani DA
    J Physiol; 2024 Mar; 602(6):1211-1225. PubMed ID: 38381050
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Maternal treatment with a placental-targeted antioxidant (MitoQ) impacts offspring cardiovascular function in a rat model of prenatal hypoxia.
    Aljunaidy MM; Morton JS; Kirschenman R; Phillips T; Case CP; Cooke CM; Davidge ST
    Pharmacol Res; 2018 Aug; 134():332-342. PubMed ID: 29778808
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Maternal antioxidant treatment protects adult offspring against memory loss and hippocampal atrophy in a rodent model of developmental hypoxia.
    Camm EJ; Cross CM; Kane AD; Tarry-Adkins JL; Ozanne SE; Giussani DA
    FASEB J; 2021 May; 35(5):e21477. PubMed ID: 33891326
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Maternal melatonin: Effective intervention against developmental programming of cardiovascular dysfunction in adult offspring of complicated pregnancy.
    Hansell JA; Richter HG; Camm EJ; Herrera EA; Blanco CE; Villamor E; Patey OV; Lock MC; Trafford AW; Galli GLJ; Giussani DA
    J Pineal Res; 2022 Jan; 72(1):e12766. PubMed ID: 34634151
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Placental treatment improves cardiac tolerance to ischemia/reperfusion insult in adult male and female offspring exposed to prenatal hypoxia.
    Hula N; Spaans F; Vu J; Quon A; Kirschenman R; Cooke CM; Phillips TJ; Case CP; Davidge ST
    Pharmacol Res; 2021 Mar; 165():105461. PubMed ID: 33513355
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Developmental programming of cardiovascular dysfunction by prenatal hypoxia and oxidative stress.
    Giussani DA; Camm EJ; Niu Y; Richter HG; Blanco CE; Gottschalk R; Blake EZ; Horder KA; Thakor AS; Hansell JA; Kane AD; Wooding FB; Cross CM; Herrera EA
    PLoS One; 2012; 7(2):e31017. PubMed ID: 22348036
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vitamin C prevents intrauterine programming of in vivo cardiovascular dysfunction in the rat.
    Kane AD; Herrera EA; Camm EJ; Giussani DA
    Circ J; 2013; 77(10):2604-11. PubMed ID: 23856654
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of the tumor necrosis factor (TNF)-related weak inducer of apoptosis (TWEAK) in offspring exposed to prenatal hypoxia.
    Reyes LM; Shah A; Quon A; Morton JS; Davidge ST
    J Dev Orig Health Dis; 2018 Dec; 9(6):661-669. PubMed ID: 29249219
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Translatable mitochondria-targeted protection against programmed cardiovascular dysfunction.
    Botting KJ; Skeffington KL; Niu Y; Allison BJ; Brain KL; Itani N; Beck C; Logan A; Murray AJ; Murphy MP; Giussani DA
    Sci Adv; 2020 Aug; 6(34):eabb1929. PubMed ID: 32875110
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Placental Adaptation to Early-Onset Hypoxic Pregnancy and Mitochondria-Targeted Antioxidant Therapy in a Rodent Model.
    Nuzzo AM; Camm EJ; Sferruzzi-Perri AN; Ashmore TJ; Yung HW; Cindrova-Davies T; Spiroski AM; Sutherland MR; Logan A; Austin-Williams S; Burton GJ; Rolfo A; Todros T; Murphy MP; Giussani DA
    Am J Pathol; 2018 Dec; 188(12):2704-2716. PubMed ID: 30248337
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Maternal Allopurinol Prevents Cardiac Dysfunction in Adult Male Offspring Programmed by Chronic Hypoxia During Pregnancy.
    Niu Y; Kane AD; Lusby CM; Allison BJ; Chua YY; Kaandorp JJ; Nevin-Dolan R; Ashmore TJ; Blackmore HL; Derks JB; Ozanne SE; Giussani DA
    Hypertension; 2018 Oct; 72(4):971-978. PubMed ID: 30354714
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MitoQ as an antenatal antioxidant treatment improves markers of lung maturation in healthy and hypoxic pregnancy.
    Lock MC; Botting KJ; Allison BJ; Niu Y; Ford SG; Murphy MP; Orgeig S; Giussani DA; Morrison JL
    J Physiol; 2023 Aug; 601(16):3647-3665. PubMed ID: 37467062
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intervention against hypertension in the next generation programmed by developmental hypoxia.
    Brain KL; Allison BJ; Niu Y; Cross CM; Itani N; Kane AD; Herrera EA; Skeffington KL; Botting KJ; Giussani DA
    PLoS Biol; 2019 Jan; 17(1):e2006552. PubMed ID: 30668572
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heart disease link to fetal hypoxia and oxidative stress.
    Giussani DA; Niu Y; Herrera EA; Richter HG; Camm EJ; Thakor AS; Kane AD; Hansell JA; Brain KL; Skeffington KL; Itani N; Wooding FB; Cross CM; Allison BJ
    Adv Exp Med Biol; 2014; 814():77-87. PubMed ID: 25015802
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vascular effects of aerobic exercise training in rat adult offspring exposed to hypoxia-induced intrauterine growth restriction.
    Reyes LM; Morton JS; Kirschenman R; DeLorey DS; Davidge ST
    J Physiol; 2015 Apr; 593(8):1913-29. PubMed ID: 25616117
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nanoparticle-encapsulated antioxidant improves placental mitochondrial function in a sexually dimorphic manner in a rat model of prenatal hypoxia.
    Ganguly E; Kirschenman R; Spaans F; Holody CD; Phillips TEJ; Case CP; Cooke CM; Murphy MP; Lemieux H; Davidge ST
    FASEB J; 2021 Feb; 35(2):e21338. PubMed ID: 33428278
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sex-Specific Effects of Nanoparticle-Encapsulated MitoQ (nMitoQ) Delivery to the Placenta in a Rat Model of Fetal Hypoxia.
    Ganguly E; Aljunaidy MM; Kirschenman R; Spaans F; Morton JS; Phillips TEJ; Case CP; Cooke CM; Davidge ST
    Front Physiol; 2019; 10():562. PubMed ID: 31178743
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic developmental hypoxia alters mitochondrial oxidative capacity and reactive oxygen species production in the fetal rat heart in a sex-dependent manner.
    Smith KLM; Swiderska A; Lock MC; Graham L; Iswari W; Choudhary T; Thomas D; Kowash HM; Desforges M; Cottrell EC; Trafford AW; Giussani DA; Galli GLJ
    J Pineal Res; 2022 Oct; 73(3):e12821. PubMed ID: 35941749
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sildenafil therapy for fetal cardiovascular dysfunction during hypoxic development: studies in the chick embryo.
    Itani N; Skeffington KL; Beck C; Giussani DA
    J Physiol; 2017 Mar; 595(5):1563-1573. PubMed ID: 27861916
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.